FAIR will combine MultiOmics and computational biology to define the contribution of flagellin towards protection and the downstream immune effectors responsible for the gain of protection during combination therapy.
This systems biology approach will be applied to animal models and human airway epithelium models. Systems biology applied to the combination of flagellin and antibiotic can shed light on mechanisms of action and also provide a framework for the discovery and development of novel antibacterial therapeutics.